Clenbuterol-Induced Myocarditis: A Case Report

Authors

• Natassja Moriarty Department of Medicine, Furness General Hospital, Barrow-in-Furness, United Kingdom
• Nadeem Attar Department of Cardiology, Furness General Hospital, Barrow-in-Furness, United Kingdom

simplysanaja@gmail.com

Keywords

Abstract

Objective: We present a case of a 22-year-old bodybuilder diagnosed with myocarditis secondary to clenbuterol use.
Results: The patient was primarily managed conservatively by the discontinuation of clenbuterol and the temporary use of dual anti-platelets, beta-blockers and nitrates.
Conclusion: Clenbuterol is a long-acting beta-2 agonist primarily used in veterinary medicine. In recent years, it has been illegally marketed as a weight loss supplement because of its anabolic properties and is popular among fitness enthusiasts. It is our aim to use this case to underscore the adverse effects of this drug with hopes that tighter regulations will be instituted to stem its illegal distribution.